# EBIO - Enthesitis Biopsy Study

> **NCT04887597** · PHASE4 · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 10 (estimated)

## Conditions studied

- Psoriatic Arthritis
- Enthesitis
- Biopsy

## Interventions

- **DRUG:** Secukinumab

## Key facts

- **NCT ID:** NCT04887597
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-18
- **Primary completion:** 2022-03
- **Final completion:** 2022-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04887597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04887597, "EBIO - Enthesitis Biopsy Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04887597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*